|
| 34146471 | A community challenge to evaluate RNA-seq, fusion detection, and isoform quantification methods for cancer discovery. | Cell Syst | 2021 |
| 29331515 | MHC class I loaded ligands from breast cancer cell lines: A potential HLA-I-typed antigen collection. | J Proteomics | 2018 |
| 27307436 | Identification of shared TCR sequences from T cells in human breast cancer using emulsion RT-PCR. | Proc Natl Acad Sci U S A | 2016 |
| 25849628 | A humanized leucine zipper-TRAIL hybrid induces apoptosis of tumors both in vitro and in vivo. | PLoS One | 2015 |
| 26075913 | TRAIL-Based High Throughput Screening Reveals a Link between TRAIL-Mediated Apoptosis and Glutathione Reductase, a Key Component of Oxidative Stress Response. | PLoS One | 2015 |
| 24771425 | Systemic effects of TRAIL (TNF-related apoptosis-inducing ligand) during acute γ-irradiation. | Bull Exp Biol Med | 2014 |
| 21518756 | Dynamic interdomain interactions contribute to the inhibition of matrix metalloproteinases by tissue inhibitors of metalloproteinases. | J Biol Chem | 2011 |
| 19551841 | Timp-2 binding with cellular MT1-MMP stimulates invasion-promoting MEK/ERK signaling in cancer cells. | Int J Cancer | 2010 |
| 20605791 | Internal cleavages of the autoinhibitory prodomain are required for membrane type 1 matrix metalloproteinase activation, although furin cleavage alone generates inactive proteinase. | J Biol Chem | 2010 |
| 19232058 | Biochemical evidence of the interactions of membrane type-1 matrix metalloproteinase (MT1-MMP) with adenine nucleotide translocator (ANT): potential implications linking proteolysis with energy metabolism in cancer cells. | Biochem J | 2009 |
| 19509255 | Engineering a leucine zipper-TRAIL homotrimer with improved cytotoxicity in tumor cells. | Mol Cancer Ther | 2009 |
| 17991754 | Tissue inhibitor of metalloproteinases-2 binding to membrane-type 1 matrix metalloproteinase induces MAPK activation and cell growth by a non-proteolytic mechanism. | J Biol Chem | 2008 |
| 18519667 | Molecular signature of MT1-MMP: transactivation of the downstream universal gene network in cancer. | Cancer Res | 2008 |
| 17761671 | Specific inhibition of autoimmune T cell transmigration contributes to beta cell functionality and insulin synthesis in non-obese diabetic (NOD) mice. | J Biol Chem | 2007 |
| 16384550 | Both PA63 and PA83 are endocytosed within an anthrax protective antigen mixed heptamer: a putative mechanism to overcome a furin deficiency. | Arch Biochem Biophys | 2006 |
| 17079467 | Membrane type-1 matrix metalloproteinase confers aneuploidy and tumorigenicity on mammary epithelial cells. | Cancer Res | 2006 |
| 16778201 | Interference with the complement system by tumor cell membrane type-1 matrix metalloproteinase plays a significant role in promoting metastasis in mice. | Cancer Res | 2006 |
| 16940151 | Mechanistic insights into targeting T cell membrane proteinase to promote islet beta-cell rejuvenation in type 1 diabetes. | FASEB J | 2006 |
| 16510592 | Matrix metalloproteinase 26 proteolysis of the NH2-terminal domain of the estrogen receptor beta correlates with the survival of breast cancer patients. | Cancer Res | 2006 |
| 16392787 | Anthrax lethal factor protease inhibitors: synthesis, SAR, and structure-based 3D QSAR studies. | J Med Chem | 2006 |
| 16636666 | Furin regulates the intracellular activation and the uptake rate of cell surface-associated MT1-MMP. | Oncogene | 2006 |
| 16627478 | O-glycosylation regulates autolysis of cellular membrane type-1 matrix metalloproteinase (MT1-MMP). | J Biol Chem | 2006 |
| 16229682 | Cleavage targets and the D-arginine-based inhibitors of the West Nile virus NS3 processing proteinase. | Biochem J | 2006 |
| 15381157 | Membrane type-1 matrix metalloproteinase (MT1-MMP) protects malignant cells from tumoricidal activity of re-engineered anthrax lethal toxin. | Int J Biochem Cell Biol | 2005 |
| 16219679 | The transmembrane domain is essential for the microtubular trafficking of membrane type-1 matrix metalloproteinase (MT1-MMP). | J Cell Sci | 2005 |
| 15944163 | Inhibition of membrane type-1 matrix metalloproteinase by cancer drugs interferes with the homing of diabetogenic T cells into the pancreas. | J Biol Chem | 2005 |
| 15878869 | Membrane type-1 matrix metalloproteinase (MT1-MMP) exhibits an important intracellular cleavage function and causes chromosome instability. | J Biol Chem | 2005 |
| 15983377 | Efficient synthetic inhibitors of anthrax lethal factor. | Proc Natl Acad Sci U S A | 2005 |
| 14645246 | The low density lipoprotein receptor-related protein LRP is regulated by membrane type-1 matrix metalloproteinase (MT1-MMP) proteolysis in malignant cells. | J Biol Chem | 2004 |
| 15574774 | Matrix metalloproteinase-26 is associated with estrogen-dependent malignancies and targets alpha1-antitrypsin serpin. | Cancer Res | 2004 |
| 15260832 | Prointegrin maturation follows rapid trafficking and processing of MT1-MMP in Furin-Negative Colon Carcinoma LoVo Cells. | Traffic | 2004 |
| 15375167 | Non-proteolytic, receptor/ligand interactions associate cellular membrane type-1 matrix metalloproteinase with the complement component C1q. | J Biol Chem | 2004 |
| 15381670 | Cellular membrane type-1 matrix metalloproteinase (MT1-MMP) cleaves C3b, an essential component of the complement system. | J Biol Chem | 2004 |
| 14729059 | Aberrant, persistent inclusion into lipid rafts limits the tumorigenic function of membrane type-1 matrix metalloproteinase in malignant cells. | Exp Cell Res | 2004 |
| 12514192 | Membrane type-1 matrix metalloproteinase functions as a proprotein self-convertase. Expression of the latent zymogen in Pichia pastoris, autolytic activation, and the peptide sequence of the cleavage forms. | J Biol Chem | 2003 |
| 11773076 | The hemopexin-like C-terminal domain of membrane type 1 matrix metalloproteinase regulates proteolysis of a multifunctional protein, gC1qR. | J Biol Chem | 2002 |
| 12220632 | The cytoplasmic tail peptide sequence of membrane type-1 matrix metalloproteinase (MT1-MMP) directly binds to gC1qR, a compartment-specific chaperone-like regulatory protein. | FEBS Lett | 2002 |
| 11724803 | Processing of integrin alpha(v) subunit by membrane type 1 matrix metalloproteinase stimulates migration of breast carcinoma cells on vitronectin and enhances tyrosine phosphorylation of focal adhesion kinase. | J Biol Chem | 2002 |
| 11741954 | An alternative processing of integrin alpha(v) subunit in tumor cells by membrane type-1 matrix metalloproteinase. | J Biol Chem | 2002 |
| 11389678 | Characterization of matrix metalloproteinase-26, a novel metalloproteinase widely expressed in cancer cells of epithelial origin. | Biochem J | 2001 |
| 11335709 | Mutation analysis of membrane type-1 matrix metalloproteinase (MT1-MMP). The role of the cytoplasmic tail Cys(574), the active site Glu(240), and furin cleavage motifs in oligomerization, processing, and self-proteolysis of MT1-MMP expressed in breast carcinoma cells. | J Biol Chem | 2001 |
| 9829941 | RecA-independent pathways of lambdoid prophage induction in Escherichia coli. | J Bacteriol | 1998 |